BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 8648375)

  • 21. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.
    Ladanyi M; Antonescu CR; Leung DH; Woodruff JM; Kawai A; Healey JH; Brennan MF; Bridge JA; Neff JR; Barr FG; Goldsmith JD; Brooks JS; Goldblum JR; Ali SZ; Shipley J; Cooper CS; Fisher C; Skytting B; Larsson O
    Cancer Res; 2002 Jan; 62(1):135-40. PubMed ID: 11782370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival in patients with synovial sarcoma of the head and neck: association with tumor location, size, and extension.
    Harb WJ; Luna MA; Patel SR; Ballo MT; Roberts DB; Sturgis EM
    Head Neck; 2007 Aug; 29(8):731-40. PubMed ID: 17274049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors in synovial sarcoma: a clinicopathologic study of 18 cases.
    Yokoyama K; Shinohara N; Kondo M; Mashima T
    Jpn J Clin Oncol; 1995 Aug; 25(4):131-4. PubMed ID: 7666589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of clinical outcomes and prognostic factors for synovial sarcoma arising from the extremities.
    Sakabe T; Murata H; Konishi E; Takeshita H; Ueda H; Matsui T; Horie N; Yanagisawa A; Kubo T
    Med Sci Monit; 2008 Jun; 14(6):CR305-310. PubMed ID: 18509273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological Profile and Survival Outcomes in Patients with Localised Extremity Synovial Sarcomas.
    Sharma J; Deo SVS; Kumar S; Barwad AW; Rastogi S; Sharma DN; Singh G; Bhoriwal S; Mishra A; K R; Saikia J; Mandal A; Bansal B; Gaur M
    Clin Oncol (R Coll Radiol); 2024 Apr; 36(4):e97-e104. PubMed ID: 38326122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic implication of SYT-SSX fusion type in synovial sarcoma: a multi-institutional retrospective analysis in Japan.
    Takenaka S; Ueda T; Naka N; Araki N; Hashimoto N; Myoui A; Ozaki T; Nakayama T; Toguchida J; Tanaka K; Iwamoto Y; Matsumine A; Uchida A; Ieguchi M; Kaya M; Wada T; Baba I; Kudawara I; Aoki Y; Yoshikawa H
    Oncol Rep; 2008 Feb; 19(2):467-76. PubMed ID: 18202796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis.
    Guillou L; Benhattar J; Bonichon F; Gallagher G; Terrier P; Stauffer E; Somerhausen Nde S; Michels JJ; Jundt G; Vince DR; Taylor S; Genevay M; Collin F; Trassard M; Coindre JM
    J Clin Oncol; 2004 Oct; 22(20):4040-50. PubMed ID: 15364967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary Metastatic Synovial Sarcoma: Experience of the CWS Study Group.
    Scheer M; Dantonello T; Hallmen E; Vokuhl C; Leuschner I; Sparber-Sauer M; Kazanowska B; Niggli F; Ladenstein R; Bielack SS; Klingebiel T; Koscielniak E
    Pediatr Blood Cancer; 2016 Jul; 63(7):1198-206. PubMed ID: 27003095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localized synovial sarcoma of the foot or ankle: A series of 32 Cooperative Weichteilsarkom Study Group patients.
    Scheer M; Greulich M; Loff S; Vokuhl C; Feuchtgruber S; von Kalle T; Münter M; Stegmaier S; Sparber-Sauer M; Kazanowska B; Niggli F; Fuchs J; Bielack SS; Klingebiel T; Koscielniak E;
    J Surg Oncol; 2019 Jan; 119(1):109-119. PubMed ID: 30421433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognosis of T1 synovial sarcoma depends upon surgery by oncologic surgeons.
    El Beaino M; Araujo DM; Gopalakrishnan V; Lazar AJ; Lin PP
    J Surg Oncol; 2016 Sep; 114(4):490-4. PubMed ID: 27220538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors in synovial sarcoma.
    Rööser B; Willén H; Hugoson A; Rydholm A
    Cancer; 1989 Jun; 63(11):2182-5. PubMed ID: 2541885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synovial sarcoma: a clinicopathological study of 36 cases.
    Golouh R; Vuzevski V; Bracko M; van der Heul RO; Cervek J
    J Surg Oncol; 1990 Sep; 45(1):20-8. PubMed ID: 1696334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment.
    Spillane AJ; A'Hern R; Judson IR; Fisher C; Thomas JM
    J Clin Oncol; 2000 Nov; 18(22):3794-803. PubMed ID: 11078492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synovial sarcoma.
    Wright PH; Sim FH; Soule EH; Taylor WF
    J Bone Joint Surg Am; 1982 Jan; 64(1):112-22. PubMed ID: 6274877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary synovial sarcoma of the kidney. A case report with pathologic appraisal investigation and literature review.
    Pitino A; Squillaci S; Spairani C; Cosimi MF; Feyles E; Ricci D; Bardari F; Graziano M; Morabito F; Cesarani F; Garruso M; Belletti M; Beierl K; Murphy KM
    Pathologica; 2011 Oct; 103(5):271-8. PubMed ID: 22393682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synovial sarcoma of the extremities: prognostic factors for 20 nonmetastatic cases and a new histologic grading system with prognostic significance.
    Baptista AM; Camargo OP; Croci AT; Oliveira CR; Azevedo Neto RS; Giannotti MA; Caiero MT; Santos TM; Abadi MD
    Clinics (Sao Paulo); 2006 Oct; 61(5):381-6. PubMed ID: 17072434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome of chemotherapy in advanced synovial sarcoma patients: Review of 15 clinical trials from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group; setting a new landmark for studies in this entity.
    Vlenterie M; Litière S; Rizzo E; Marréaud S; Judson I; Gelderblom H; Le Cesne A; Wardelmann E; Messiou C; Gronchi A; van der Graaf WT
    Eur J Cancer; 2016 May; 58():62-72. PubMed ID: 26968015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synovial sarcoma. Large size predicts poor outcome.
    Thompson RC; Garg A; Goswitz J; Cheng EY; Clohisy DR; Dusenbery K
    Clin Orthop Relat Res; 2000 Apr; (373):18-24. PubMed ID: 10810458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ki-67 is strongly prognostic in synovial sarcoma: analysis based on 86 patients from the Scandinavian Sarcoma group register.
    Skytting BT; Bauer HC; Perfekt R; Nilsson G; Larsson O
    Br J Cancer; 1999 Aug; 80(11):1809-14. PubMed ID: 10468301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors that govern localized synovial sarcoma: a single institution retrospective study on 51 patients.
    Yaser S; Salah S; Al-Shatti M; Abu-Sheikha A; Shehadeh A; Sultan I; Salem A; Sughayer M; Al-Loh S; Al-Mousa A
    Med Oncol; 2014 Jun; 31(6):958. PubMed ID: 24770952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.